Soleno Therapeutics (SLNO) Current Leases (2019 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Current Leases of $1.2 million for Q1 2026, up 93.83% year-over-year from $600000.0 in Q1 2025, and up 66.14% quarter-over-quarter from $700000.0 in Q4 2025.
Soleno Therapeutics (SLNO) Current Leases (2019 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Current Leases for 8 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 93.83% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 93.83% YoY), while the FY2025 annual figure was $700000.0, up 40.0% from the prior year.
- Current Leases climbed to $1.2 million in Q1 2026 per SLNO's latest filing, from $700000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.2 million in Q1 2026 and bottomed at $39000.0 in Q1 2023.
- Historically, Current Leases has averaged $420941.2 across 5 years, with a median of $300000.0 in 2022.
- Annual changes were most pronounced in 2023 — Current Leases sank 87.0% — and 2024, when it jumped 669.23%.
- Soleno Therapeutics' Current Leases stood at $155000.0 in 2022, then soared by 76.13% to $273000.0 in 2023, then surged by 83.15% to $500000.0 in 2024, then jumped by 40.0% to $700000.0 in 2025, then surged by 66.14% to $1.2 million in 2026.
- Business Quant data shows SLNO's Current Leases at $1.2 million in Q1 2026, $700000.0 in Q4 2025, and $697000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 697,000.00 |
| Jun 30, 2025 | 676,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 448,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 273,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 155,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 337,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 282,000.00 |
| Sep 30, 2021 | 290,000.00 |
| Jun 30, 2021 | 180,000.00 |